Exa Specialities And Lifecare Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 08-12-2024
- Paid Up Capital ₹ 5.00 M
as on 08-12-2024
- Company Age 7 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 3.00 Cr
as on 08-12-2024
- Satisfied Charges ₹ 4.56 Cr
as on 08-12-2024
- Revenue 1.67%
(FY 2021)
- Profit 401.24%
(FY 2021)
- Ebitda -26.51%
(FY 2021)
- Net Worth 13.52%
(FY 2021)
- Total Assets -10.13%
(FY 2021)
About Exa Specialities And Lifecare
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 5.00 M.
The company currently has active open charges totaling ₹3.00 Cr. The company has closed loans amounting to ₹4.56 Cr, as per Ministry of Corporate Affairs (MCA) records.
Ganesan Subramani and Raj Mani serve as directors at the Company.
- CIN/LLPIN
U74999MH2017PTC296493
- Company No.
296493
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
22 Jun 2017
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Exa Specialities And Lifecare Private Limited offer?
Exa Specialities And Lifecare Private Limited offers a wide range of products and services, including Cardiovascular Drugs & Medication, Immunosuppressive Drugs, Anti Infective Drugs & Medicines, Antiparasitic Drug, TB, Tumor & Cancer Drugs, Anti Cancer Medicines, Pain Relief Drugs & Pharmaceuticals, Osteoporosis Medications, Nutraceuticals & Dietary Supplements, Nutraceuticals.
Who are the key members and board of directors at Exa Specialities And Lifecare?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ganesan Subramani  | Director | 22-Jun-2017 | Current |
| Raj Mani | Director | 22-Jun-2017 | Current |
Financial Performance of Exa Specialities And Lifecare.
Exa Specialities And Lifecare Private Limited, for the financial year ended 2021, experienced modest growth in revenue, with a 1.67% increase. The company also saw a substantial improvement in profitability, with a 401.24% increase in profit. The company's net worth Soared by an impressive increase of 13.52%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Exa Specialities And Lifecare?
In 2021, Exa Specialities And Lifecare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 14 Mar 2024 | ₹3.00 Cr | Open |
Axis Bank Limited Creation Date: 10 Mar 2021 | ₹2.81 Cr | Satisfied |
Tjsb Sahakari Bank Limited Creation Date: 10 Jan 2018 | ₹1.75 Cr | Satisfied |
How Many Employees Work at Exa Specialities And Lifecare?
Unlock and access historical data on people associated with Exa Specialities And Lifecare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Exa Specialities And Lifecare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Exa Specialities And Lifecare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
